Median Technologies S.A. | Small-cap | Healthcare
€2.58
9.79%
| Median Technologies Stock Comparison:
Median Technologies vs Guerbet S.AMedian Technologies vs Eurobio ScientificMedian Technologies vs Affluent MedicalMedian Technologies vs Novacyt S.AMedian Technologies vs Theraclion S.AMedian Technologies vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2018

Income Metrics

EPS (Diluted) €0.00

Balance Sheet Metrics

Total Assets 24.4M
Total Liabilities 58.3M
Shareholders Equity -34.0M

Cash Flow Metrics

Revenue & Profitability Trend

Median Technologies Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i22.9M22.2M23.7M20.5M13.5M
Cost of Goods Sold i-886.0K-1.0M-750.0K117.0K135.0K
Gross Profit i23.8M23.2M24.4M20.4M13.3M
Gross Margin % i103.9%104.5%103.2%99.4%99.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i1.3M739.0K759.0K421.0K281.0K
Other Operating Expenses i18.3M18.5M17.8M13.3M9.3M
Total Operating Expenses i19.6M19.3M18.6M13.7M9.6M
Operating Income i-22.4M-22.9M-23.2M-11.4M-8.7M
Operating Margin % i-97.5%-103.0%-97.9%-55.7%-64.7%
Non-Operating Items
Interest Income i-----
Interest Expense i3.8M1.9M1.3M1.2M789.0K
Other Non-Operating Income-----
Pre-tax Income i-25.1M-22.9M-19.7M-18.9M-12.8M
Income Tax i144.0K76.0K521.0K437.0K-8.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-25.2M-23.0M-20.2M-19.3M-12.8M
Net Margin % i-110.0%-103.4%-85.4%-93.9%-95.0%
Key Metrics
EBITDA i-20.3M-21.8M-22.4M-10.5M-8.2M
EPS (Basic) i€-1.37€-1.25€-1.28€-1.25€-1.06
EPS (Diluted) i€-1.37€-1.25€-1.28€-1.25€-1.06
Basic Shares Outstanding i1849378218376380157782481547024812115224
Diluted Shares Outstanding i1849378218376380157782481547024812115224

Income Statement Trend

Median Technologies Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i8.1M19.5M21.5M39.0M16.3M
Short-term Investments i151.0K123.0K200.0K241.0K83.0K
Accounts Receivable i7.5M6.6M6.0M5.0M4.3M
Inventory i48.0K102.0K000
Other Current Assets-1.0K-1.0K-1.0K-1.0K
Total Current Assets i20.5M31.9M31.5M47.5M23.4M
Non-Current Assets
Property, Plant & Equipment i5.9M5.4M4.8M1.8M1.4M
Goodwill i2.0M1.7M963.0K72.0K57.0K
Intangible Assets i2.0M1.7M963.0K72.0K57.0K
Long-term Investments-----
Other Non-Current Assets-2.0K-1.0K1.0K2.0K
Total Non-Current Assets i3.9M4.0M3.2M1.8M1.9M
Total Assets i24.4M35.9M34.8M49.4M25.3M
Liabilities
Current Liabilities
Accounts Payable i3.2M3.8M3.7M3.1M2.6M
Short-term Debt i20.5M736.0K530.0K374.0K350.0K
Current Portion of Long-term Debt-----
Other Current Liabilities4.8M5.1M4.7M3.8M3.2M
Total Current Liabilities i44.1M22.7M23.4M27.3M20.3M
Non-Current Liabilities
Long-term Debt i9.0M19.2M17.6M16.1M16.4M
Deferred Tax Liabilities i254.0K225.0K277.0K241.0K237.0K
Other Non-Current Liabilities-1.0K1.0K--1.0K-
Total Non-Current Liabilities i14.2M23.5M18.6M17.2M16.3M
Total Liabilities i58.3M46.2M42.0M44.4M36.6M
Equity
Common Stock i926.0K920.0K790.0K775.0K607.0K
Retained Earnings i-25.2M-23.0M-20.2M-19.3M-12.8M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i-34.0M-10.3M-7.3M4.9M-11.4M
Key Metrics
Total Debt i29.4M20.0M18.2M16.5M16.8M
Working Capital i-23.6M9.2M8.1M20.3M3.1M

Balance Sheet Composition

Median Technologies Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-25.2M-23.0M-20.2M-19.3M-12.8M
Depreciation & Amortization i-----
Stock-Based Compensation i1.4M2.8M7.9M1.8M267.0K
Working Capital Changes i00000
Operating Cash Flow i-20.1M-18.5M-10.8M-15.9M-11.8M
Investing Activities
Capital Expenditures i-227.0K-1.3M-1.4M-437.0K-293.0K
Acquisitions i000--
Investment Purchases i-86.0K00-229.0K-26.0K
Investment Sales i027.0K039.0K58.0K
Investing Cash Flow i-313.0K-1.3M-1.4M-627.0K-261.0K
Financing Activities
Share Repurchases i--76.0K-42.0K--58.0K
Dividends Paid i-----
Debt Issuance i8.5M3.2M0015.0M
Debt Repayment i-----360.0K
Financing Cash Flow i8.6M21.6M123.0K33.6M14.6M
Free Cash Flow i-19.0M-21.5M-17.2M-10.6M-5.8M
Net Change in Cash i-11.8M1.8M-12.1M17.0M2.6M

Cash Flow Trend

Median Technologies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -1.84
Forward P/E -2.41
Price to Sales 3.99

Profitability Ratios

Profit Margin -109.93%
Operating Margin -76.84%
Return on Equity 74.31%
Return on Assets -46.71%

Financial Health

Current Ratio 0.46
Debt to Equity -0.98
Beta 0.65

Per Share Data

EPS (TTM) €-1.37
Book Value per Share €-1.84
Revenue per Share €1.24

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
almdt91.7M-1.84-74.31%-109.93%-0.98
Guerbet S.A 293.8M18.030.733.50%1.89%100.91
Eurobio Scientific 251.9M64.361.412.26%2.58%5.46
Affluent Medical 60.0M-4.301.95-48.69%-275.50%0.54
Novacyt S.A 34.8M-0.800.70-57.28%-212.73%24.81
Theraclion S.A 31.4M-5.58--203.90%-346.01%-66,510.16

Financial data is updated regularly. All figures are in the company's reporting currency.